(.ALPHA.S)-N-((1S,3S,4S)-4-((2-(2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-((1S)-1-METHYLPROPYL)-2-OXO-1(2H)-PYRIMIDINEACETAMIDE
UNII G2LP85XNK9
Substance Identification & Data
This profile provides standardized clinical and technical data for (.alpha.s)-n-((1s,3s,4s)-4-((2-(2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-.alpha.-((1s)-1-methylpropyl)-2-oxo-1(2h)-pyrimidineacetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G2LP85XNK9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1132765-59-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C38H50N4O5 YORYEDPQPARBHF-KPWATQDOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (.alpha.s)-n-((1s,3s,4s)-4-((2-(2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-.alpha.-((1s)-1-methylpropyl)-2-oxo-1(2h)-pyrimidineacetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.